Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. (ALPN) Revenue
Annual & quarterly revenue history · segment & region breakdown
ALPN · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAlpine Immune Sciences, Inc. trailing twelve-month (TTM) revenue is $0.06B, an increase of 95.84% year-over-year from $0.06B in FY2023.
Revenue trend
2023 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-12-31 | $0.06B | +$0.03B | +95.84% |
| 2022-12-31 | $0.03B | +$0.01B | +28.24% |
| 2021-12-31 | $0.02B | +$0.01B | +151.13% |
| 2020-12-31 | $0.01B | +$0.01B | +436.49% |
| 2019-12-31 | $0.00B | +$0.00B | +146.81% |
| 2018-12-31 | $0.00B | -$0.00B | -59.27% |
| 2017-12-31 | $0.00B | -$0.00B | -41.32% |
| 2016-12-31 | $0.00B | +$0.00B | +499.59% |
| 2015-12-31 | $0.00B | +$0.00B | — |
| 2014-12-31 | $0.00B | +$0.00B | — |
Compare revenue vs peers
BiotechnologyCompare ALPN revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Alpine Immune Sciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Alpine Immune Sciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Alpine Immune Sciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ALPN revenue · 4 questionsALPN's trailing twelve-month (TTM) revenue is $0.06B. That is an increase of 95.84% year-over-year from $0.06B in FY2023.
▸ Source: FMP · Alpine Immune Sciences, Inc. SEC filings · GAAP · Alpine Immune Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026